ARTICLE | Clinical News
ItMSCs: Phase IIa started
February 24, 2014 8:00 AM UTC
Stemedica's CardioCell LLC subsidiary began a double-blind, placebo-controlled, U.S. Phase IIa trial to evaluate a single dose of IV itMSCs in about 50 patients with ST-segment elevation MI (STEMI). ...